Parthenon Therapeutics
PrivateLast Round
Series A
Nov 3, 2021
Total Funding Raised
$65M
Company Overview
Parthenon Therapeutics is a biotechnology company that invents a novel class of anti-cancer therapies that reprogram the tumor microenvironment (TME).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Parthenon Therapeutics Comparables
Compare Parthenon Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImmunoGenesis | 83% | |
| Apmonia Therapeutics | 78% | |
| Alentis Therapeutics | 74% | |
Parthenon Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 3, 2021 |
Parthenon Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series A |
| Creacion Ventures | Series A |
| Taiho Ventures | Series A |
| Northpond Ventures | Series A |
| Tekla Capital Management | Series A |
| Breakout Ventures | Series A |
| Alexandria Venture Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 2, 2026
Monthly visitors increased 160% MoM, reaching 2K.
- Nov 9, 2024
Monthly visitors increased 40% MoM.
Parthenon Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Parthenon Therapeutics's valuation, stock price, and market status.